Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2174-2178
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2174
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2174
Table 2 Comparison of patients with and without recurrence of primary HCC in the liver.
Variable | With recurrence(n = 12) | Without recurrence(n = 14) | P |
Age (yr) | 67.8 ± 5.7 | 67.9 ± 7.8 | NS |
Gender | |||
Male | 6 | 11 | NS |
Female | 6 | 3 | |
Nodule diameter (mm) | 23.5 ± 7.2 | 32.0 ± 24.2 | NS |
Number of primary | |||
HCC nodules | |||
Uninodular | 3 | 10 | <0.05 |
Multinodular | 9 | 4 | |
Child-Pugh A | 6 | 9 | NS |
B | 6 | 5 | |
Platelet (/mL) | 8.2 ± 3.6 | 13.3 ± 6.9 | <0.05 |
Albumin (g/L) | 3.2 ± 0.3 | 3.4 ± 0.4 | NS |
AST (IU/L) | 197.7 ± 416.0 | 87.2 ± 47.2 | NS |
Post-RFA AST (IU/L) | 72.4 ± 25.4 | 70.8 ± 2.96 | NS |
ALT (IU/L) | 98.0± 121.6 | 76 ± 43.5 | NS |
Post-RFA ALT (IU/L) | 49.3 ±21.4 | 55.4 ± 30.5 | NS |
Post-RFA treatment | |||
UDCA | 10 | 12 | NS |
SNMC | 5 | 4 | |
IFN | 0 | 2 |
- Citation: Yamanaka Y, Shiraki K, Miyashita K, Inoue T, Kawakita T, Yamaguchi Y, Saitou Y, Yamamoto N, Nakano T, Nakatsuka A, Yamakado K, Takeda K. Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. World J Gastroenterol 2005; 11(14): 2174-2178
- URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2174